Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Unnamed Molecular Glue Program (Evogene)
- Development stage
- Preclinical
- Lead developer
- Evogene
- Modality
- Molecular Glues → Targeted Protein Degraders (TPDs) → Small Molecules
01
Overview
The Unnamed Molecular Glue Program is a preclinical drug discovery initiative by Evogene, developed in collaboration with an undisclosed biotechnology partner. The program leverages Evogene's ChemPass AI™ platform to identify and optimize small molecule molecular glues. These compounds are designed to modulate protein-protein interactions (PPIs) by either stabilizing or disrupting the interface between two proteins. Molecular glues typically function by inducing proximity between a target protein and another protein, such as an E3 ubiquitin ligase, to facilitate therapeutic outcomes like targeted protein degradation or functional modulation of previously 'undruggable' targets.
- Other names
- Evogene Molecular Glue ProgramPPI Molecular Glue Program
Beyond the preview
Go deeper on Unnamed Molecular Glue Program (Evogene).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Unnamed Molecular Glue Program (Evogene).